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Abstract
In this article, we examine selected health indicators for the adult population aged 18 years and older in Germany 
(n=22,708) from the German Health Update (GEDA 2019/2020-EHIS) conducted between April 2019 and September 
2020. These indicators include those of self-assessed health and depressive symptoms as well as chronic physical 
diseases and conditions. In young adulthood (18 to 44 years), over 80% of participants report good or very good subjective 
health. During this phase of life, most chronic diseases and conditions are rare, although allergies are frequent, and 
bronchial asthma and depressive symptoms are not uncommon. From mid adulthood (45 years and older), there is a 
gradual increase in the prevalence of chronic diseases such as cardiovascular disease, diabetes, chronic obstructive 
pulmonary disease and osteoarthritis. Over 60% of older adults (65 years and older) report a chronic disease or long-
term health problem, while only half continue to report good or very good subjective health. During this stage of life, 
allergies and depressive symptoms become less prevalent. For some diseases, there are also differences according to 
gender and level of education. This article demonstrates the high public health relevance of age-associated chronic 
physical diseases and health related limitations in everyday life in an ageing society as well as the need to provide care 
for certain health conditions already in young adulthood.
 SUBJECTIVE HEALTH · DEPRESSIVE SYMPTOMS · CHRONIC DISEASES · HEALTH MONITORING
1. Introduction
As a population-representative health survey of the adult 
population in Germany, the German Health Update (GEDA) 
is an important component of continuous health monitor-
ing at the Robert Koch Institute (RKI) [1]. Since 2014/2015, 
the questionnaire of the European Health Interview Survey 
(EHIS), which is conducted every five years to assess the 
health situation of the population aged 15 years and older, 
has been incorporated into GEDA [2]. The GEDA part on 
health problems and diseases focuses on self-assessed 
general health, health disorders and the resulting limita-
tions in everyday life as well as mental health and common 
non-communicable diseases. The reason for this focus lies 
in the fact that chronic conditions and non-communicable 
diseases and their risk factors dominate morbidity and 
mortality in European countries and interact with the per-
sistent threat from infectious diseases [3]. For example, the 
widespread prevalence of non-communicable diseases, mul-
timorbidity and frailty in the population has contributed 
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to the severe health consequences of the current global 
COVID-19 pandemic [4, 5]. Conversely, we cannot rule out 
the possibility that chronic health issues will increase at 
the population level in the context of the pandemic. These 
could include complications following infection with SARS-
CoV-2 and indirect health consequences of the pandemic 
caused by restricted social contact and by other non-phar-
maceutical measures of infection control [6–8]. This rein-
forces the demands of international health organisations 
for targeted health surveillance to prevent and control 
non-communicable diseases and to promote physical and 
mental health on a national and global level [9, 10]. 
The standardised EHIS questionnaire, approved at Euro-
pean level, comprises four modules for collecting data on 
health status, health determinants, health care and socio-
demographic background [2]. The Minimum European 
Health Module (MEHM) consists of three main health sta-
tus indicators: self-assessment of general health (subjec-
tive health), presence of chronic diseases or long-term 
health problems, and presence of health-related limitations 
in usual everyday activities [11]. The information collected 
in GEDA can be used to monitor further indicators, includ-
ing individual chronic diseases, accidents and injuries, 
depressive symptoms and functional aspects of health such 
as pain, restrictions to mobility and the need for help in 
everyday life [2].
Based on data from GEDA 2019/2020-EHIS, this article 
provides an initial overview of the current health of adults 
in Germany using selected indicators. The data collection 
was conducted between April 2019 and September 2020 
and thus includes the period of severe contact restrictions 
imposed in response to the COVID-19 pandemic between 
mid-March and early June 2020. However, this article aims 
to assess the health situation over the entire survey period. 
Findings on the above-mentioned indicators of health sta-
tus, chronic non-communicable diseases of particular pub-
lic health relevance and depressive symptomatology as an 
indicator of mental health are differentiated by age group 
and gender with the goal of mapping health within differ-
ent phases of adulthood. Differences in education are 
reported in relation to health inequalities. 
2. Methodology
2.1 Study design and sample
The German Health Update (GEDA) is a cross-sectional 
survey based on a nationwide sample of the resident pop-
ulation in Germany. The GEDA study has been conducted 
by the Robert Koch Institute (RKI) on behalf of the Ger-
man Federal Ministry of Health at multi-year intervals since 
2008 and is part of the health monitoring at the RKI [1, 12]. 
The fifth follow-up survey, GEDA 2019/2020-EHIS, took 
place between April 2019 and September 2020. As in the 
2014/2015 wave, the questionnaire of the European Health 
Interview Survey (EHIS) was fully integrated [2, 13]. GEDA 
2019/2020-EHIS was conducted as a telephone interview 
survey using a computer assisted, fully structured interview 
(i.e. Computer Assisted Telephone Interview, CATI). It was 
based on a random sample of landline and mobile tele-
phone numbers (dual-frame method) [14]. The target pop-
ulation comprised the population aged 15 years and older 
living in private households and with permanent residency 
in Germany. A total of 23,001 people provided complete 
interviews. GEDA 2019/2020-EHIS used gender identities 
GEDA 2019/2020-EHIS  
Fifth follow-up survey of the  
German Health Update
Data holder: Robert Koch Institute
Objectives: Provision of reliable information on 
the health status, health behaviour and health 
care of the population living in Germany, with 
the possibility of European comparisons 
Study design: Cross-sectional telephone survey 
Population: German-speaking population aged 
15 and older living in private households that 
can be reached via landline or mobile phone
Sampling: Random sample of landline and 
mobile telephone numbers (dual-frame 
method) from the ADM sampling system 
(Arbeitskreis Deutscher Markt- und Sozial-
forschungsinstitute e.V.)
Sample size: 23,001 respondents
Study period: April 2019 to September 2020
GEDA survey waves: 
  GEDA 2009
  GEDA 2010
  GEDA 2012
  GEDA 2014/2015-EHIS
  GEDA 2019/2020-EHIS
Further information in German is available at 
www.geda-studie.de
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The response options were ‘yes’, ‘no’ or ‘don’t know’. The 
indicator for health-related limitations in usual everyday 
activities (Global Activity Limitation Indicator, GALI) was 
measured using a two-stage approach. The initial question 
was: ‘Are you limited by a health problem in activities of 
your normal everyday life? Would you say you are...’ with 
the response options being ‘... severely limited’, ‘... mod-
erately limited’ and ‘... not limited’. Respondents who gave 
one of the first two response options were asked further: 
‘How long have you been limited?’. Response options were 
‘less than 6 months’ and ‘6 months or longer’. 
Depressive symptoms 
The presence of depressive symptoms in the past two weeks 
was used as an indicator of mental health and was recorded 
via participants’ self-assessment using the internationally 
established 8-item Patient Health Questionnaire (PHQ-8) 
[18]. With this questionnaire, the symptoms of major 
depression occurring in the past two weeks are rated 
according to the Diagnostic and Statistical Manual of Men-
tal Disorders (DSM-IV, 4th edition [19]) as ‘not at all’, ‘sev-
eral days’, ‘more than half of the days’ or ‘nearly every day’. 
The presence of depressive symptoms is assumed from a 
sum score of at least ten of the maximum of 24 points.
Chronic physical diseases and health conditions 
Data on the 12-month prevalence of chronic diseases and 
health problems are based on responses to the following 
question: ‘This section deals with lasting diseases and 
chronic health problems. Please do not include tempo-
rary health problems. In the past 12 months, have you had 
any of the following diseases or health problems?’. A list 
to describe gender differences and allowed the respon-
dents to indicate which gender they feel they belong to. 
Respondents 15 years and older included 12,101 women 
and 10,838 men. 62 respondents provided a different gen-
der identity to the one that they were assigned at birth or 
gave no information. These individuals are not included in 
the gender stratified analyses. Based on the standards of 
the American Association for Public Opinion Research 
(AAPOR), the response rate was 21.6% (RR3) [15]. A 
detailed description of the methodology used for GEDA 
2019/2020-EHIS, including a differentiated presentation 
of the response rates, can be found in Allen et al. in this 
issue of the Journal of Health Monitoring [16].
2.2 Indicators
Self-assessed health status 
Data on three health status indicators were collected as 
part of the MEHM and as a central component of all nation-
al health surveys in the European Union [11, 17]. The indi-
cator for subjective health is measured with the following 
question on self-assessed general health, as recommend-
ed by the World Health Organization (WHO): ‘How is your 
health in general?’. Participants were asked to choose one 
of five response options: ‘very good’, ‘good’, ‘fair’, ‘bad’ or 
‘very bad’. The nationwide health monitoring defines the 
answers ‘very good’ or ‘good’ as a positively perceived sub-
jective health. The indicator for a chronic disease or long-
term health problem was collected via the following ques-
tion: ‘Do you have any chronic disease or a long-term health 
problem? This means diseases or health problems that 
have lasted or are expected to last for at least 6 months’. 
Journal of Health Monitoring 2021 6(3)
Health situation of adults in GermanyJournal of Health Monitoring
6
FOCUS
as prevalence in percentages with a 95% confidence inter-
val (95% CI) for women and men separated by age group 
(18- to 29-year-olds, 30- to 44-year-olds, 45- to 64-year-olds, 
65- to 79-year-olds, and at least 80 year-olds) and accord-
ing to education level (International Standard Classifica-
tion of Education, ISCED: low, medium and high educa-
tion group). 
The analyses were carried out using a weighting factor 
to correct for deviations of the sample from the population 
structure. Design weighting was first carried out for the 
different selection probabilities (mobile and landline). This 
was followed by an adjustment to the official population 
figures based on age, sex, federal state and district type (as 
of 31 December 2019). Adjustments were also undertaken 
to ensure the data reflected the education distribution iden-
tified by the 2017 microcensus. This was conducted in 
accordance with ISCED classifications [20].
The analyses were carried out with SAS 9.4. In order to 
take the weighting appropriately into account when calcu-
lating the confidence intervals and p-values, all analyses 
were calculated using the SAS survey procedures. A statis-
tically significant difference between groups is assumed if 
the corresponding p-value in the Rao-Scott Chi-Square test 
is less than 0.05.
3. Results 
3.1 Self-assessed health status 
Overall, 69.9% (95% CI 69.0%–70.9%) of participants rat-
ed their subjective health as very good or good, with the 
proportion of women (68.6%) being slightly lower than 
that of men (71.6%). Both genders perceived their health 
included in the questionnaire asked specific questions 
about individual diseases and complaints, with possible 
answers being ‘yes’, ‘no’ or ‘don’t know’. This article con-
siders the information collected on diabetes mellitus 
(queried as ‘diabetes, not gestational diabetes’), coronary 
heart disease (CHD, queried as ‘heart attack’, ‘chronic con-
sequences of heart attack’ and ‘coronary heart disease or 
angina pectoris’), stroke or chronic consequences of stroke 
(queried as ‘stroke’ and ‘chronic consequences of stroke’), 
chronic obstructive pulmonary disease (COPD, queried as 
‘chronic bronchitis, chronic obstructive pulmonary disease, 
emphysema’), bronchial asthma (queried as ‘asthma, 
including allergic asthma’), allergies (queried as ‘allergies 
such as hay fever, allergic reactions of the eyes or skin, food 
allergies or other allergies, not including allergic asthma’) 
and osteoarthritis (queried as ‘osteoarthritis, not including 
rheumatoid arthritis or joint inflammation’). 
2.3 Statistical analyses
The analyses are based on data from 22,708 participants 
aged between 18 and 99 years (11,959 women, 10,687 men, 
and 62 participants who reported a different or no gender 
identity). For each indicator, participants who did not pro-
vide information for the variables on which a specific indi-
cator is based were excluded from the analyses (12 for 
subjective health, 69 for chronic disease/long-term health 
problem, 57 for long-term health-related limitation in every-
day activities, 447 for depressive symptoms, 34 for diabe-
tes, 122 for CHD, 16 for stroke/chronic consequence of 
stroke, 26 for bronchial asthma, 42 for COPD, 85 for aller-
gies and 159 for osteoarthritis). The results are presented 
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for men (46.4%). The corresponding proportion increased 
with increasing age from 33.8% for women and 25.8% for 
men in the youngest age group to 61.9% for women and 
62.0% for men in the oldest age group. 
Long-term health-related limitations in usual everyday 
activities were reported by 33.4% (95% CI 32.4%–34.4%) 
of the participants. The prevalence was higher for women 
(35.5%) than for men (31.0%). A substantial increase in the 
considerably poorer with increasing age (Table 1). Thus, in 
the youngest age group (18 to 29 years), 87.2% of women 
and 88.3% of men regarded their health as very good or 
good compared to 42.5% of women and 52.6% of men in 
the oldest age group (80 years and older). 
49.2% (95% CI 48.2%–50.2%) of the participants 
reported a chronic disease or a long-term health problem; 
this proportion was slightly higher for women (51.9%) than 
Table 1 
Prevalence of subjective health rated as very 
good or good (n=11,953 women, n=10,681 men), 
of chronic diseases or long-term health 
problems (n=11,916 women, n=10,662 men) 
and long-term health-related limitations 
in usual everyday activities 
(n=11,929 women, n=10,664 men) 
by gender, age and education level 
Source: GEDA 2019/2020-EHIS
Subjective health 
(very good or good)
Chronic disease or 
health problem
(at least six months)
Health-related limitation in 
usual everyday activities
(severe or moderate, 
at least six months) 
% (95% CI) % (95% CI) % (95% CI)
Women (total) 68.6 (67.2–69.9) 51.9 (50.6–53.3) 35.5 (34.2–36.9)
Age group
18–29 years 87.2 (83.5–90.1) 33.8 (29.8–38.0) 16.8 (13.7–20.5)
30–44 years 82.9 (80.1–85.3) 40.9 (37.8–44.0) 21.3 (18.7–24.2)
45–64 years 66.0 (63.9–68.1) 58.6 (56.6–60.6) 39.2 (37.2–41.3)
65–79 years 55.3 (52.6–57.9) 61.9 (59.4–64.5) 46.1 (43.5–48.8)
≥80 years 42.5 (37.9–47.3) 61.9 (57.0–66.6) 63.2 (58.5–67.7)
Education level
Low education group 53.5 (49.5–57.5) 56.1 (52.0–60.1) 47.3 (43.3–51.3)
Medium education group 69.1 (67.5–70.7) 53.0 (51.3–54.7) 35.3 (33.7–37.0)
High education group 82.1 (80.6–83.4) 45.2 (43.3–47.1) 24.5 (23.0–26.1)
Men (total) 71.6 (70.2–72.9) 46.4 (44.9–47.8) 31.0 (29.7–32.4)
Age group
18–29 years 88.3 (85.2–90.8) 25.8 (22.6–29.2) 10.5 (8.4–13.1)
30–44 years 84.0 (81.2–86.4) 34.6 (31.6–37.8) 18.5 (16.0–21.3)
45–64 years 65.2 (62.8–67.5) 53.1 (50.8–55.4) 38.8 (36.5–41.3)
65–79 years 57.7 (54.6–60.8) 63.8 (60.9–66.7) 42.9 (39.9–46.0)
≥80 years 52.6 (47.1–58.0) 62.0 (56.6–67.1) 58.1 (52.6–63.4)
Education level
Low education group 63.8 (58.5–68.8) 49.1 (43.8–54.4) 39.4 (34.2–44.8)
Medium education group 68.3 (66.4–70.2) 48.0 (46.0–50.1) 33.3 (31.4–35.3)
High education group 81.2 (80.0–82.3) 42.3 (40.8–43.9) 23.1 (21.9–24.5)
CI=confidence interval
Subjective health is rated 
less favourably with 
increasing age, with fewer 
women than men reporting 
their subjective health as 
good or very good.
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3.3 Chronic physical diseases and health conditions
Cardiometabolic diseases
Overall, 8.9% (95% CI 8.4%–9.5%) of adults reported the 
presence of diabetes mellitus (excluding gestational dia-
betes) in the past twelve months, with the prevalence for 
women (8.2%) being lower than for men (9.6%) (Table 3). 
In young adulthood (up to 44 years of age), the prevalence 
for both women and men is still below 3.5%, but then rises 
prevalence of health-related limitations can be seen with 
increasing age, from 16.8% for women and 10.5% for men 
in the youngest age group to 63.2% for women and 58.1% 
for men in the oldest age group. 
For all three indicators, there is a pronounced educa-
tional gradient, particularly for women, with a lower preva-
lence of very good or good subjective health and a higher 
prevalence of chronic diseases or long-term health prob-
lems as well as of long-term health-related limitations in 
everyday life in the low education group compared to the 
high education group. Such a pattern largely persists across 
the age groups (Annex Table 1). 
3.2 Depressive symptoms 
A total of 8.3% (95% CI 7.7%–9.0%) of adults reported 
depressive symptoms within the previous two weeks. 
8.8% of women and 7.5% of men are affected (Table 2). 
In the youngest adult age group (up to 29 years), more 
women tend to be affected. Depressive symptoms were 
least likely to be reported in the 65- to 79-year-old age 
group. For both women and men, the frequency of depres-
sive symptoms decreases with higher levels of education. 
Compared to the high education group, almost three 
times as many women in the lower education group and 
four times as many men are affected by depressive symp-
toms. An analysis of depressive symptoms by age and 
education group (Annex Table 2) shows that the differ-
ences between the genders diminish with increasing age 
and higher education.
Table 2 
Prevalence of depressive symptoms 
in the past two weeks based on PHQ-8  
by gender, age and education level 
(n=11,703 women, n=10,503 men) 
Source: GEDA 2019/2020-EHIS
Depressive symptoms 
(in the past two weeks)
% (95% CI)
Women (total) 8.8 (8.0–9.7)
Age group
18–29 years 11.6 (8.8–15.1)
30–44 years 8.7 (6.8–10.9)
45–64 years 10.2 (8.8–11.7)
65–79 years 5.0 (3.9–6.3)
≥80 years 7.3 (4.9–10.7)
Education level
Low education group 13.0 (10.4–16.1)
Medium education group 8.5 (7.4–9.6)
High education group 5.7 (4.8–6.8)
Men (total) 7.5 (6.7–8.5)
Age group
18–29 years 7.3 (5.3–10.0)
30–44 years 7.3 (5.5–9.5)
45–64 years 9.6 (8.0–11.5)
65–79 years 4.4 (3.1–6.3)
≥80 Jahre 5.8 (3.8–8.7)
Education level
Low education group 13.4 (9.9–17.9)
Medium education group 8.4 (7.1–9.8)
High education group 3.4 (2.8–4.0)
CI=confidence interval, PHQ-8=8-item Patient Health Questionnaire
Depressive symptoms are 
more prevalent in young  
and mid-adulthood.
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A total of 2.3% (95% CI 2.0%–2.6%) of adults reported 
a stroke or chronic consequences of stroke in the past 
twelve months, with women (2.1%) and men (2.3%) show-
ing similar prevalence estimates. In young adulthood, preva-
lence is still below 1% for both genders and then rises to 
5.5% in women in the age group 80 years and older and to 
6.2% in men aged 65 to 79 years.
For the cardiometabolic diseases under consideration, 
a clear educational gradient can be observed in women, with 
with age, reaching 17.9% in women and 22.3% in men in 
the oldest age group. 
A total of 5.8% (95% CI 5.4%–6.3%) of adults reported 
CHD (i.e. heart attack, chronic consequences of a heart 
attack, coronary heart disease or angina pectoris) in the past 
twelve months, with the prevalence in women (5.1%) also 
lower than in men (6.6%). Cases of CHD are rare in young 
adulthood for both genders (less than 1%) and rise with age 
to 18.9% in women and 21.9% in men in the oldest age group. 
Table 3 
12-month prevalence of diabetes 
(n=11,942 women, n=10,671 men), 
coronary heart disease 
(n=11,904 women, n=10,621 men) 
and stroke or consequences of stroke 
(n=11,953 women, n=10,678 men) 
by gender, age and education level
Source: GEDA 2019/2020-EHIS
Diabetes Coronary heart disease Stroke
% (95% CI) % (95% CI) % (95% CI)
Women (total) 8.2 (7.5–9.1) 5.1 (4.5–5.7) 2.1 (1.7–2.6)
Age group
18–29 years 0.81 (0.2–2.6)
0.82 (0.5–1.4) 0.62 (0.2–1.4)
30–44 years 3.2 (2.1–4.9)
45–64 years 7.1 (6.0–8.3) 3.6 (2.7–4.6) 1.9 (1.3–2.7)
65–79 years 17.0 (15.0–19.3) 9.2 (7.8–10.9) 3.9 (3.0–5.0)
≥80 years 17.9 (14.4–22.0) 18.9 (15.3–23.1) 5.5 (3.6–8.5)
Education level
Low education group 13.5 (11.0–16.4) 9.8 (7.7–12.4) 3.9 (2.6–5.8)
Medium education group 7.9 (7.1–8.8) 4.3 (3.7–5.0) 1.9 (1.5–2.5)
High education group 3.9 (3.4–4.5) 2.3 (1.9–2.8) 0.9 (0.7–1.2)
Men (total) 9.6 (8.8–10.5) 6.6 (5.9–7.4) 2.3 (1.9–2.8)
Age group
18–29 years 0.6 (0.3–1.2)
0.42 (0.2–0.8) 0.11.2 (0.0–0.4)
30–44 years 2.7 (1.7–4.3)
45–64 years 11.2 (9.7–13.0) 6.4 (5.2–7.7) 2.4 (1.7–3.2)
65–79 years 20.0 (17.7–22.5) 16.5 (14.2–19.1) 6.2 (4.7–8.0)
≥80 years 22.3 (18.1–27.2) 21.9 (17.7–26.8) 5.9 (3.9–8.8)
Education level
Low education group 8.8 (6.2–12.3) 6.5 (4.3–9.6) 2.1 (0.9–4.7)
Medium education group 10.8 (9.7–12.2) 7.1 (6.1–8.2) 2.6 (2.1–3.3)
High education group 7.6 (6.9–8.3) 5.8 (5.2–6.5) 1.8 (1.4–2.2)
CI=confidence interval
1 Number of cases is n<10
2 Estimate refers to the age group 18–44 years
The prevalences of diabetes, 
coronary heart disease, 
stroke and its sequelae as 
well as chronic obstructive 
pulmonary disease increase 
considerably from mid- to 
older adulthood and are 
lower or similar in women 
compared to men.
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being affected more often than men (27.0%) (Table 5). An 
allergy was mainly reported in young and mid-adulthood 
(women up to 64 years, men up to 44 years). In addition, 
women in the high education group more frequently report-
ed an allergy than women in the low education group. 
Osteoarthritis
A total of 17.1% (95% CI 16.4%–17.8%) of adults report-
ed having osteoarthritis in the past twelve months, with 
prevalence estimates around twice as high in the medium 
education group and around three times as high in the 
lower education group compared to the higher education 
group. In men, the lowest prevalence estimates are also 
found in the high education group, but the differences of 
the high education group with the medium and low edu-
cation groups are much less pronounced and, in some 
cases, not statistically significant.
Diseases of the lower respiratory tract 
A total of 6.1% (95% CI 5.6%–6.7%) of adults reported 
the presence of COPD in the past twelve months. Preva-
lences for women (6.5%) and men (5.8%) are similar 
(Table 4). COPD prevalence increases with age from less 
than 2% in both genders for the 18- to 29-year age group 
to 10.9% for women in the 80 years and older age group 
and 10.4% for men in the 65- to 79-year age group. Con-
siderable differences regarding levels of education can be 
observed for both genders, with higher prevalences in the 
low and medium education groups compared to the high 
education group.
The prevalence of bronchial asthma (including allergic 
asthma) in the past twelve months for adults was 8.0% 
(95% CI 7.5%–8.6%), with women (9.1%) more frequently 
affected than men (7.0%). Prevalence estimates are similar 
for women and men across all age groups and no statisti-
cally significant differences by education group are evident.
Allergies
The presence of (any) allergy (except allergic asthma) in the 
past twelve months was reported by almost one-third of 





% (95% CI) % (95% CI)
Women (total) 6.5 (5.8–7.2) 9.1 (8.3–9.9)
Age group
18–29 years 1.2 (0.5–2.6) 7.4 (5.5–9.9)
30–44 years 3.9 (2.6–5.8) 8.5 (6.9–10.6)
45–64 years 7.7 (6.5–9.0) 10.7 (9.4–12.1)
65–79 years 9.0 (7.7–10.6) 8.6 (7.3–10.0)
≥80 years 10.9 (8.1–14.6) 7.9 (5.6–11.0)
Education level
Low education group 9.4 (7.3–12.1) 10.0 (7.9–12.6)
Medium education group 6.4 (5.6–7.3) 9.0 (8.1–10.1)
High education group 3.4 (2.9–4.0) 8.1 (7.1–9.1)
Men (total) 5.8 (5.1–6.6) 7.0 (6.3–7.7)
Age group
18–29 years 1.5 (0.8–2.9) 6.5 (4.9–8.5)
30–44 years 2.4 (1.5–3.7) 6.7 (5.4–8.3)
45–64 years 7.5 (6.1–9.1) 7.2 (6.0–8.7)
65–79 years 10.4 (8.4–12.7) 7.4 (5.9–9.1)
≥80 years 9.4 (6.7–13.0) 6.7 (4.5–10.0)
Education level
Low education group 8.6 (6.0–12.4) 7.3 (5.0–10.5)
Medium education group 6.4 (5.4–7.5) 7.4 (6.4–8.6)
High education group 3.5 (3.1–4.1) 6.1 (5.4–6.9)
CI=confidence interval
Table 4 
12-month prevalence of chronic 
obstructive pulmonary disease 
(n=11,940 women, n=10,665 men) 
and bronchial asthma 
(n=11,946 women, n=10,675 men) 
by gender, age and education level
Source: GEDA 2019/2020-EHIS
The prevalence of asthma 
does not change with age, 
while the prevalence of  
allergies is highest in young 
and mid-adulthood; both of 
these chronic conditions are 
more prevalent in women 
than in men.
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In this article, we present current data on selected indica-
tors of physical and mental health among adults in Ger-
many, which are collected every five years as part of EHIS 
integrated into the nationwide GEDA study. 
The results are differentiated according to five age 
groups, each representing a phase of life, and by gender. 
From the age of 45 years, the prevalence of subjective health 
women (21.6%) being affected markedly more often than 
men (12.4%) (Table 6). For both genders, prevalence does 
not substantially exceed 5% in young adulthood, but then 
increases with age to 47.3% in the oldest women and 
31.6% in the oldest men. While a clear educational gra-
dient is evident for women with the lowest prevalence 
found in the high education group and the highest preva-
lence in the low education group, no such gradient is 
found for men.
Table 5 (left) 
12-month prevalence of allergies 
by gender, age and education level 
(n=11,918 women, n=10,645 men) 
Source: GEDA 2019/2020-EHIS
Table 6 (right) 
12-month prevalence of osteoarthritis 
by gender, age and education level 




Women (total) 34.7 (33.4–36.0)
Age group
18–29 years 37.9 (33.8–42.1)
30–44 years 41.0 (37.9–44.1)
45–64 years 37.3 (35.3–39.3)
65–79 years 27.4 (25.2–29.7)
≥80 years 20.1 (16.5–24.2)
Education level
Low education group 31.0 (27.4–34.8)
Medium education group 35.2 (33.6–36.9)
High education group 36.7 (34.9–38.5)
Men (total) 27.0 (25.7–28.3)
Age group
18–29 years 39.3 (35.6–43.0)
30–44 years 32.7 (29.7–35.7)
45–64 years 23.9 (22.0–25.9)
65–79 years 17.3 (15.3–19.5)
≥80 years 16.1 (12.6–20.4)
Education level
Low education group 25.6 (21.2–30.5)
Medium education group 26.4 (24.6–28.2)
High education group 28.9 (27.4–30.4)
CI=confidence interval
Osteoarthritis
% (95%  CI)
Women (total) 21.6 (20.5–22.7)
Age group
18–29 years 1.11 (0.4–2.9)
30–44 years 5.1 (3.8–6.7)
45–64 years 23.9 (22.1–25.8)
65–79 years 39.7 (37.2–42.4)
≥80 years 47.3 (42.4–52.1)
Education level
Low education group 31.2 (27.7–34.9)
Medium education group 21.0 (19.8–22.4)
High education group 13.5 (12.5–14.6)
Men (total) 12.4 (11.5–13.4)
Age group
18–29 years 1.11 (0.5–2.6)
30–44 years 3.5 (2.5–5.1)
45–64 years 15.4 (13.8–17.2)
65–79 years 23.2 (20.7–26.0)
≥80 years 31.6 (26.7–36.9)
Education level
Low education group 13.3 (10.0–17.4)
Medium education group 12.8 (11.5–14.1)
High education group 11.4 (10.5–12.3)
CI=confidence interval 
1 Number of cases is n<10
Osteoarthritis is one of  
the most common chronic 
diseases in the elderly  
population and is more  
prevalent in women  
than in men.
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4.1 Self-assessed health status 
Subjective health primarily reflects how well a person feels. 
A less favourable self-assessment of health is associated 
with a higher prevalence of chronic diseases and health 
problems [21–23] and is also an important predictor of pre-
mature mortality [24]. Based on the present study, around 
70% of all adults in Germany rate their subjective health 
as very good or good; about half report a chronic disease 
or a long-term health problem and a third report severe or 
moderate long-term health-related limitations in usual 
everyday activities, each of which have lasted at least six 
months. Over the course of life, subjective health is 
assessed more negatively as age increases, and the pres-
ence of chronic diseases or health problems as well as of 
health-related limitations are correspondingly reported 
more frequently. This pattern over the course of life points 
to the association between self-assessed subjective health 
and the actual state of health. Said differently, the more 
frequently people report chronic diseases, health problems 
or health-related limitations, the more negatively they 
assess their state of health; a finding that is also in line 
with other studies [21–23]. In comparison to earlier RKI 
surveys, the proportions of women and men with very good 
or good subjective health were similar in the three tele-
phone surveys GEDA 2009 to 2012 and somewhat lower 
in GEDA 2014/2015-EHIS, which collected data in writing 
or online [25]. The collection of data for the indicators on 
chronic diseases and long-term health problems as well as 
on long-term health-related limitations in usual everyday 
activities differed in previous GEDA waves to the one used 
here, which limits the possibilities for comparisons over 
assessed as good or very good declines substantially to 
43% for women and 53% for men, and health-related limi-
tations in usual everyday activities lasting at least six 
months rise considerably to 63% for women and 58% for 
men. The prevalence of having (any) chronic disease or 
long-term health problem for at least six months increases 
gradually with age in both genders. Among the individ-
ual chronic diseases examined, CHD, diabetes, COPD 
and osteoarthritis characteristically increase in middle 
age (45 years and older) for both genders, with 12-month 
prevalences in the oldest age group for both women and 
men of around 6% for stroke, around 20% for diabetes 
and CHD, around 10% for COPD and for osteoarthritis, 
47% in women and 32% in men. In contrast, depressive 
symptoms in the previous two weeks are especially com-
mon in young and mid-adulthood with prevalences 
between 7% and 12% for both genders. A similar picture 
emerges for allergies, which, with a 12-month prevalence 
of around 40%, are most frequently reported by women 
in young and mid-adulthood and by men in young adult-
hood. Only bronchial asthma exhibits no significant dif-
ferences in 12-month prevalence across the age range for 
both genders. 
With the exception of bronchial asthma and allergies, 
all the health indicators considered show an educational 
gradient to the disadvantage of adults with lower levels of 
education. For most of the indicators, this is particularly 
pronounced in women, and for osteoarthritis, it only affects 
women. Conversely, a higher prevalence of allergies is 
observed in women with a high level of education.
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case in GEDA 2014/2015-EHIS. Only in the age group 65 
years and older does prevalence decrease, as it also does 
for women. Differences in the prevalence of depressive 
symptoms according to levels of education have tended to 
increase rather than decrease. Further in-depth trend analy-
ses would be needed to determine whether this develop-
ment is due to a worsening of the situation for people in 
the low education group or an improvement in the situa-
tion for higher education groups. The complexity of the 
possible backgrounds and causal relationships is discussed, 
for example, in the current Health Situation of Women in 
Germany Report [28] and the Focus Report on Mental 
Health [29] of the RKI. In any case, this is a possible indi-
cation that current preventive approaches, such as the 
expansion of the Occupational Health and Safety Act 
through risk assessment (sub-para. 6 in §5 of the Occupa-
tional Health and Safety Act, ArbSchG) should be reviewed 
to see how effectively they also reach the population with 
lower levels of education. 
4.3 Chronic physical diseases and health conditions
Cardiometabolic diseases
The metabolic disease diabetes mellitus, which is charac-
terised by a disturbance of blood sugar level regulation, 
plays an important role from mid-adulthood onwards. 
Thus, data on 12-month prevalence show that in the age 
range 45 to 64 years almost one in ten people and from 
65 years even one in five people report a diabetes. Overall, 
women are affected less frequently than men, and the low 
and medium education groups are affected more often 
than the high education group. These age, gender and 
time. In the present study, gender-, age- and education-spe-
cific differences in the prevalences of all three indicators 
were observed, which could enable approaches for the 
improvement of target group-specific prevention measures 
as well as health promotion and health care. 
4.2 Depressive symptoms 
Depressive symptoms not only occur with depression but 
can also be accompanying or secondary symptoms of oth-
er mental disorders or physical diseases or refer to sub-
clinical forms of depression. It should therefore be noted 
that the PHQ-8 questionnaire-based indicator for depres-
sive symptoms correlates with almost all domains of men-
tal health and covers a total of eight symptom domains. 
For reasons of space, however, this article only presents 
the total score. Especially in young adulthood, women 
are more frequently affected by depressive symptoms. 
Earlier analyses of time trends have shown that there can 
be considerable changes within the different age groups. 
An analysis on major depression, for example, showed 
that the prevalence of depression among 18- to 34-year-
old women almost doubled from 8.8% to 15.6% between 
1998 and 2011, while the prevalence decreased from 9.8% 
to 5.0% among 50- to 65-year-old women [26]. Analyses 
of GEDA 2014/2015-EHIS data also showed that younger 
women are affected by depressive symptoms more fre-
quently than older women [27]. The current analyses of 
self-reported depressive symptoms in the past two weeks 
replicate this finding, indicating entrenched risks for 
younger women. No obvious differences were observed 
for men in the age groups up to 64 years, as was also the 
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5.1% for women and 6.6% for men described here differ 
slightly from the age-standardised CHD prevalence of 3.9% 
for women and 8.0% for men calculated on the basis of 
the 2018 ambulatory claims data [36]. This difference could 
be caused by the relatively low case number for men from 
the low education group in GEDA, which may have led to 
an underestimation of CHD prevalence in men. This small 
number of cases may also have contributed to the study 
result that the known social status gradient for CHD is not 
pronounced among men, although it is clearly evident in 
women [37]. As both the cited study and GEDA data show, 
men are more likely to develop CHD than women. This has 
been observed in many studies [38]. In GEDA 2019/2020-
EHIS, 2.1% of women and 2.3% of men answered yes to 
the question of whether they had had a stroke or chronic 
consequences of stroke in the past twelve months. These 
prevalence estimates were slightly lower in GEDA 
2014/2015-EHIS [39], but due to the method ological dif-
ferences between the two surveys, comparisons should 
be interpreted with caution. Furthermore, as expected, 
the 12-month prevalence is lower than the lifetime preva-
lence of stroke in 40- to 79-year-old women (2.5%) and 
men (3.3%), which was surveyed in the German Health 
Interview and Examination Survey for Adults (DEGS1, 
2008–2011) [40]. As in previous surveys, there is also an 
age and education gradient for stroke [39] that is less pro-
nounced than in CHD. Limiting factors here are the low 
participation rate for men with low levels of education 
and the question of whether the EHIS indicator is suit-
able for recording stroke prevalence in the population in 
a European comparison, as already discussed in regard 
to GEDA 2014/2015-EHIS [39]. Data on cardiovascular 
education-specific differences have also been observed in 
previous studies [30–32]. Beyond the age of 45 years, dia-
betes usually develops as type 2 diabetes. Gestational dia-
betes, which becomes relevant for women in young adult-
hood, was explicitly excluded from the question in GEDA 
2019/2020-EHIS. Also disregarded in the present study are 
undiagnosed cases of diabetes, which contribute around 
2% to the overall prevalence of diabetes in the adult pop-
ulation [30]. While the prevalence of undiagnosed diabetes 
has decreased over the past few decades, the prevalence 
of diagnosed diabetes has increased [33]. The current preva-
lence estimate is also slightly higher than that reported by 
GEDA 2014/2015-EHIS [31]. This may be due to various 
factors, such as an earlier diagnosis of diabetes, improved 
care for diagnosed cases and the demographic ageing of 
the population [33]. As described in the context of the dia-
betes surveillance in Germany established at the RKI, dia-
betes and its concomitant and secondary diseases adverse-
ly impact quality of life, reduce a person’s healthy life years 
and lower life expectancy [34, 35]. For this reason, in addi-
tion to optimal medical care oriented to the needs of those 
affected, increased primary preventive behavioural and 
settings-based measures are necessary to prevent the devel-
opment of diabetes and consequently to reduce the preva-
lence of diabetes in the population.
With almost three million cases, diseases of the circu-
latory system were the most common reason for hospital-
isation in 2019 and with over 330,000 deaths, they were 
also the most common cause of death. Cardiovascular dis-
eases were not surveyed comprehensively in the context 
of GEDA 2019/2020-EHIS, but only on the basis of the 
defined EHIS indicators. The 12-month CHD prevalence of 
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as of incidence and mortality rates from malignant tumours 
of the lungs, bronchi and trachea, has been observed for 
some time [42]. COPD is one of the leading causes of pre-
mature mortality, diminished quality of life and health- 
related impairment when performing everyday activities 
[41]. At an epidemiological level, this means that contin-
uous health monitoring and embedding COPD in NCD 
surveillance are central building blocks for the promotion 
of public health.
Bronchial asthma is a chronic respiratory disease char-
acterised by symptoms such as wheezing, shortness of 
breath and breathlessness, as well as a feeling of tightness 
in the chest or coughing. Similar to allergies, a number of 
disease mechanisms play a role in asthma, and there are 
allergic and non-allergic forms [43]. The current study indi-
cates no variation by age in the overall 12-month prevalence 
of asthma in adults (8%), yet there is a gender difference 
already documented in numerous epidemiological studies, 
with women affected more frequently (9% versus 7% in 
men). In addition to this gender difference, the present 
study shows a known tendency toward higher prevalence 
estimates in lower education groups, although this is not 
statistically significant. The prevalence of asthma in GEDA 
2014/2015-EHIS was slightly lower [44]. Bronchial asthma 
is one of the most common chronic diseases worldwide. 
Increasing numbers of people are affected, necessitating 
further efforts in prevention, diagnosis and care.
Allergies
Allergy symptoms such as a runny nose, fits of sneezing, 
burning and watery eyes, breathing difficulties and even 
breathlessness or severe itching of the skin are caused by 
diseases, such as those collected here, help to determine 
the extent of the diseases within the population, to plan 
targeted prevention and care services and to monitor 
their effects.
Diseases of the lower respiratory tract 
Irreversible and chronically progressive damage to the lung 
tissue in COPD leads to a permanent narrowing of the air-
ways, overinflation of the lungs and obstruction of gas 
exchange, resulting in shortness of breath. Because COPD 
is difficult to assess, GEDA uses a variety of terms in its 
question (chronic bronchitis, chronic obstructive pulmo-
nary disease, emphysema) in accordance with internation-
al epidemiological studies [41]. It should be noted that 
self-reports lead to considerably lower prevalence estimates 
of COPD than those based on pulmonary function tests, 
which can detect early stages [41]. The indicator used in 
GEDA 2019/2020-EHIS was also used in GEDA 2014/2015-
EHIS. Although a direct comparison between the two sur-
vey waves is limited, mainly due to changes in sampling 
design, the results are very similar, particularly for men, and 
show 12-month prevalence estimates rising from the age 
of 45 years for both genders [41]. As expected, there are edu-
cational differences in the prevalence of COPD for both 
genders, reflecting inequalities in terms of the major risk 
factors (i.e. tobacco and pollutant exposure). For women, 
the prevalence has increased in comparison to GEDA 
2014/2015-EHIS [41]. This most likely reflects gender-relat-
ed changes in smoking behaviour, with a decrease in the 
proportion of male smokers and a further long-term 
increase in the proportion of female smokers. A conver-
gence of COPD mortality rates in women and men, as well 
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diseases in old age. Compared to the results from GEDA 
2014/2015-EHIS, the 12-month prevalence of osteoarthri-
tis has remained fairly stable [48]. Women suffer from 
osteoarthritis significantly more often than men; the caus-
es of this can be hormonal, metabolic or diet-related dif-
ferences [49]. The clearly pronounced educational gradient 
found in women potentially indicates a connection between 
heavy physical labour and the development of osteoarthri-
tis [50, 51]. The pain and loss of function associated with 
osteoarthritis can lead to a reduction in quality of life. Pre-
ventive measures include avoiding being overweight or 
overworking the joints [50, 51]. 
4.4 Strengths and limitations 
The short reference period of the EHIS indicators, which 
were introduced to harmonise European health monitoring 
[13, 17], as well as the high number of cases surveyed in 
GEDA 2019/2020-EHIS enable the assessment of current 
mental and physical burdens and subjective health for adults 
in Germany as well as showing the patterns specific to dif-
ferent life stages. However, the relatively short reference 
period and the self-assessment of the considered EHIS indi-
cators lead to prevalence estimates that are considerably 
different in some cases to those found in other health mon-
itoring studies and epidemiological studies, which usually 
survey the lifetime prevalence of physician-diagnosed dis-
eases based on medical interviews or examinations. 
When comparing prevalences found in GEDA 2019/2020- 
EHIS and GEDA 2014/2015-EHIS, which was conducted 
five years earlier, the differences in study design must be 
taken into account, despite the largely identical operational-
excessive reactions of the immune system to substances 
(allergens) in the environment that are harmless in them-
selves. At a clinical level, there are diverse disease entities, 
for example, allergic rhinitis (hay fever), allergic bronchial 
asthma, atopic dermatitis, allergic contact eczema and 
food allergy [45]. The allergies indicator presented in this 
article (in contrast to reported medical diagnoses) maps 
the self-assessment of being currently (i.e. in the twelve 
months prior to the survey) affected by (any) allergic dis-
ease other than bronchial asthma. The results show that 
almost one-third of adult women and men in Germany are 
affected by allergies. Compared to the previous GEDA study 
(GEDA 2014/2015-EHIS), the overall 12-month prevalence 
of allergies has increased [46]. As expected, women (35%) 
are affected more frequently than men (27%). The higher 
prevalence of allergies observed among women with a high-
er level of education is also well-documented, while aspects 
of socialisation, awareness and use of medical services are 
of particular importance. A differentiated survey of individ-
ual allergic conditions would enable more specific analyses 
of associated factors such as age, gender and level of edu-
cation. It is being discussed that for people who suffer from 
allergies, structural improvements to the health care sys-
tem, such as a structured treatment programme for aller-
gies (disease management programme, DMP), analogous 
to those for asthma and COPD, would be very helpful [45]. 
Osteoarthritis
Osteoarthritis is a degenerative disease of the joint carti-
lage that affects the adjacent muscles, joint capsules and 
ligaments [47]. Osteoarthritis is particularly widespread in 
the elderly population and is one of the most common 
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ple, may have made individual population groups easier 
(or harder) to reach by telephone. 
The present study includes indicators that were selected 
because of their relatively high prevalence in the popula-
tion and that also represent a broad spectrum of health 
complaints. When interpreting the results, it should be 
noted that the indicators occur within different time frames. 
4.5 Conclusion 
The current nationwide health monitoring data from GEDA 
2019/2020-EHIS presented here demonstrate that age- 
related, non-communicable diseases and health-related 
limitations in usual everyday activities are of high public 
health relevance in a society faced with demographic 
change. A comprehensive need to provide care for health 
problems is nevertheless not limited to the elderly. Aller-
gies and depressive symptoms are particularly prevalent 
among women and men in young and mid-adulthood, and 
bronchial asthma occurs with similar frequency across all 
age groups. Today as in the past, levels of education reflect 
differences in the prevalence of good subjective health, 
depressive symptoms, health-related limitations in every-
day life and those non-communicable diseases that are 
among the leading causes of premature mortality, espe-
cially cardiovascular diseases, diabetes and COPD. With a 
knowledge of key avoidable risk factors common to these 
diseases, nationwide health monitoring has the task of 
mapping the development of risk factors and resources as 
well as measures to promote healthy behaviour and a 
healthy living environment in a timely manner. Internation-
al health targets such as the sustainability goals of the 
isation of most indicators, as they may have led to differ-
ences in the participants involved (for example, differences 
in the distribution of participants by education level). While 
GEDA 2014/2015-EHIS utilised paper and online question-
naires that were completed by each participant based on 
a population registry sample [2], GEDA 2019/2020-EHIS 
was conducted as a telephone interview survey based on 
a random sample of landline and mobile phone numbers 
[16]. Despite weighting the respective study population by 
age, sex, region and education level according to the com-
position of the population at the time of the survey – an 
approach discussed in more detail in relation to GEDA 
2019/2020-EHIS in an article by Allen et al. in this issue of 
the Journal of Health Monitoring [16] – deviations in the 
study population with regard to other characteristics can-
not be ruled out. Comparability with earlier GEDA survey 
waves (Infobox) conducted as telephone surveys on the 
basis of random samples of landline numbers is also lim-
ited as operationalisation of most indicators differ from 
those of the EHIS surveys. Furthermore, the GEDA 
2019/2020-EHIS survey period partly coincided with the 
COVID-19 pandemic. The present results are based on the 
assumption that the sample was not systematically biased 
by the measures to contain the COVID-19 pandemic. More-
over, initial analyses do not reveal a systematic selection 
bias between the subsamples from the comparison peri-
ods April 2019 to mid-March 2020 (onset of extensive 
measures to contain the pandemic) and mid-March to Sep-
tember 2020. Nevertheless, a change in willingness to par-
ticipate and its effect on the results cannot be completely 
ruled out. The uptake of shorter working hours and an 
increase in flexible working from home solutions, for exam-
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United Nations 2030 Agenda can serve as a guideline here, 
but they must be geared toward the specific challenges of 
each country and region [52]. Preventive measures must 
above all be reviewed to determine how well they also reach 
disadvantaged groups such as people with lower levels of 
education. Health monitoring in this context has the impor-
tant task of ensuring methodological comparability over 
time. It was not possible to conduct a regionalised analy-
sis at the federal state level based on this initial evaluation. 
In future, GEDA offers the prospect of further expanding 
regionalised data analyses so as to enable more detailed 
sub-regional analyses in collaboration with the federal 
states. European comparisons will be possible in the future 
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Annex Table 1 
Prevalence of subjective health rated as very 
good or good (n=11,953 women, n=10,681 men), 
chronic diseases or long-term health problems 
(n=11,916 women, n=10,662 men) 
and long-term health-related limitations in 
usual everyday activities 
(n=11,929 women, n=10,664 men) 
by gender, age and education level
Source: GEDA 2019/2020-EHIS
Subjective health 
(very good or good)
Chronic disease or 
health problem
(at least six months)
Health-related limitation in 
usual everyday activities
(severe or moderate, 
at least six months) 
% (95% CI) % (95% CI) % (95% CI)
Women (total) 68.6 (67.2–69.9) 51.9 (50.6–53.3) 35.5 (34.2–36.9)
Age group and education level
18–29 years 87.2 (83.5–90.1) 33.8 (29.8–38.0) 16.8 (13.7–20.5)
Low education group 78.1 (67.1–86.2) 36.8 (26.8–48.0) 25.4 (16.6–36.9)
Medium education group 87.4 (82.4–91.1) 33.9 (28.7–39.6) 16.3 (12.5–21.0)
High education group 95.0 (91.4–97.1) 31.3 (24.9–38.4) 10.6 (7.0–15.5)
30–44 years 82.9 (80.1–85.3) 40.9 (37.8–44.0) 21.3 (18.7–24.2)
Low education group 74.1 (61.8–83.5) 34.4 (23.5–47.3) 25.5 (16.3–37.6)
Medium education group 81.0 (77.1–84.4) 44.7 (40.4–49.1) 23.3 (19.7–27.4)
High education group 89.6 (86.5–92.1) 37.6 (34.0–41.3) 16.4 (13.6–19.7)
45–64 years 66.0 (63.9–68.1) 58.6 (56.6–60.6) 39.2 (37.2–41.3)
Low education group 50.4 (42.8–58.0) 67.4 (59.6–74.4) 49.3 (41.6–56.9)
Medium education group 65.5 (63.0–68.0) 59.6 (57.1–62.0) 40.7 (38.3–43.3)
High education group 78.6 (76.5–80.6) 49.0 (46.6–51.5) 27.7 (25.5–29.9)
65–79 years 55.3 (52.6–57.9) 61.9 (59.4–64.5) 46.1 (43.5–48.8)
Low education group 46.1 (39.2–53.1) 62.4 (55.3–69.0) 52.4 (45.3–59.3)
Medium education group 56.4 (53.4–59.3) 61.8 (58.9–64.6) 44.5 (41.6–47.5)
High education group 67.6 (64.6–70.5) 62.1 (59.0–65.0) 40.8 (37.8–44.0)
≥80 years 42.5 (37.9–47.3) 61.9 (57.0–66.6) 63.2 (58.5–67.7)
Low education group 37.9 (29.9–46.7) 61.1 (52.2–69.4) 66.5 (57.9–74.1)
Medium education group 46.1 (40.8–51.4) 62.3 (56.8–67.4) 60.3 (54.9–65.4)
High education group 53.4 (46.5–60.0) 65.1 (58.4–71.4) 58.5 (51.6–65.0)
CI=confidence interval
Continued on next page
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Annex Table 1 Continued 
Prevalence of subjective health rated as very 
good or good (n=11,953 women, n=10,681 men), 
chronic diseases or long-term health problems 
(n=11,916 women, n=10,662 men) 
and long-term health-related limitations in 
usual everyday activities 
(n=11,929 women, n=10,664 men) 
by gender, age and education level
Source: GEDA 2019/2020-EHIS
Subjective health 
(very good or good)
Chronic disease or 
health problem
(at least six months)
Health-related limitation in 
usual everyday activities
(severe or moderate, 
at least six months) 
% (95% CI) % (95% CI) % (95% CI)
Men (total) 71.6 (70.2–72.9) 46.4 (44.9–47.8) 31.0 (29.7–32.4)
Age group and education level
18–29 years 88.3 (85.2–90.8) 25.8 (22.6–29.2) 10.5 (8.4–13.1)
Low education group 80.9 (72.4–87.3) 31.8 (24.4–40.3) 14.8 (9.6–22.2)
Medium education group 89.8 (85.8–92.8) 23.5 (19.5–28.0) 9.8 (7.2–13.1)
High education group 94.4 (90.8–96.6) 25.0 (20.0–30.7) 7.4 (4.7–11.5)
30–44 years 84.0 (81.2–86.4) 34.6 (31.6–37.8) 18.5 (16.0–21.3)
Low education group 74.3 (61.8–83.8) 32.7 (22.0–45.5) 25.1 (15.7–37.5)
Medium education group 80.4 (76.4–83.9) 39.1 (34.6–43.8) 22.1 (18.5–26.3)
High education group 92.8 (90.6–94.5) 29.5 (26.2–33.1) 10.9 (8.7–13.6)
45–64 years 65.2 (62.8–67.5) 53.1 (50.8–55.4) 38.8 (36.5–41.3)
Low education group 47.4 (37.4–57.6) 66.8 (56.5–75.7) 61.9 (51.5–71.3)
Medium education group 60.1 (56.8–63.4) 55.8 (52.5–59.0) 42.8 (39.5–46.2)
High education group 80.4 (78.4–82.2) 43.6 (41.2–46.0) 23.6 (21.7–25.7)
65–79 years 57.7 (54.6–60.8) 63.8 (60.9–66.7) 42.9 (39.9–46.0)
Low education group 48.5 (34.3–62.9) 67.4 (52.0–79.8) 55.0 (40.3–68.9)
Medium education group 53.1 (48.7–57.5) 65.8 (61.5–69.8) 45.0 (40.7–49.4)
High education group 68.1 (65.3–70.7) 59.9 (57.1–62.6) 36.3 (33.6–39.0)
≥80 years 52.6 (47.1–58.0) 62.0 (56.6–67.1) 58.1 (52.6–63.4)
Low education group 54.5 (34.9–72.8) 67.0 (46.4–82.7) 63.7 (43.1–80.2)
Medium education group 48.0 (40.5–55.5) 62.1 (54.5–69.1) 58.8 (51.2–66.0)
High education group 58.6 (53.2–63.8) 60.4 (55.0–65.6) 54.2 (48.9–59.5)
CI=confidence interval
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Annex Table 2 
Prevalence of depressive symptoms 
in the past two weeks based on PHQ-8 
by gender, age and education level 
(n=11,703 women, n=10,503 men) 
Source: GEDA 2019/2020-EHIS
% (95% CI)
Women (total) 8.8 (8.0–9.7)





























































CI=confidence interval, PHQ-8=8-item Patient Health Questionnaire 
1 Number of cases is n<10
% (95% CI)
Men (total) 7.5 (6.7–8.5)
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